23.35
price down icon1.23%   -0.29
pre-market  시장 영업 전:  23.54   0.19   +0.81%
loading

Janux Therapeutics Inc (JANX) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
기간 3개월 3개월 3개월 3개월 3개월
Revenues
-
- - 0.439 8.897
Research and Development
38.35%
34.66
25.05 - - -
Operating Income/Loss
29.29%
-45.12
-34.90 -29.02 -35.84 -13.82
Nonoperating Income/Loss
1.13%
11.26
11.39 8.806 7.783 7.863
Income/Loss From Continuing Operations Before Tax
44.03%
-33.86
-23.51 -20.22 -28.06 -5.959
Income/Loss From Continuing Operations After Tax
44.03%
-33.86
-23.51 -20.22 -28.06 -5.959
Net Income/Loss
44.03%
-33.86
-23.51 -20.22 -28.06 -5.959
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.18%
61.90
61.79 1.0345 54.63 54.45
Diluted Average Shares
0.18%
61.90
61.79 1.0345 54.63 54.45
Basic Earnings Per Share
44.74%
-0.55
-0.38 -0.35 -0.51 -0.11
Diluted Earnings Per Share
44.74%
-0.55
-0.38 -0.35 -0.51 -0.11
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.78
price up icon 0.98%
$84.84
price up icon 1.00%
$24.80
price down icon 8.06%
$103.01
price down icon 1.70%
$134.53
price up icon 1.79%
biotechnology ONC
$300.14
price down icon 2.84%
자본화:     |  볼륨(24시간):